Literature DB >> 2168481

Differential antagonism by 1,3-dipropylxanthine-8-cyclopentylxanthine and 9-chloro-2-(2-furanyl)-5,6-dihydro-1,2,4-triazolo(1,5-c)quinazolin-5-im ine of the effects of adenosine derivatives in the presence of isoprenaline on contractile response and cyclic AMP content in cardiomyocytes. Evidence for the coexistence of A1- and A2-adenosine receptors on cardiomyocytes.

N Behnke1, W Müller, J Neumann, W Schmitz, H Scholz, B Stein.   

Abstract

The antagonism by the A1-adenosine receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) and the A2-adenosine receptor antagonist [9-chloro-2-(2-furanyl)-5,6-dihydro-1,2,4-triazolo (1,5-c)quinazolin-5-imine] (CGS 15943A) of the effects of the A1-adenosine receptor agonist (-)-N6-phenylisopropyladenosine (R-PIA) and the A2-adenosine receptor agonist 5'-N-ethyl-carboxamideadenosine (NECA) in the presence of isoprenaline on contractile response and cyclic AMP (cAMP) content in cardiomyocytes from guinea pig cardiac ventricles were studied. In electrically driven (1 Hz) guinea pig ventricular cardiomyocytes R-PIA concentration-dependently (0.0001-100 microM) reduced the stimulatory effects of isoprenaline (0.01 microM) on contractile response and on cAMP content. The A1-adenosine receptor antagonist DPCPX (0.3 microM) antagonized the effects of R-PIA on contractile reponse and on cAMP content, whereas the A2-adenosine receptor antagonist CGS 15943A (0.01 microM) was ineffective. NECA (0.0001-100 microM) reduced the effects of isoprenaline (0.01 microM) on contractile response to about the same extent as R-PIA. However, NECA did not change cAMP content. DPCPX (0.3 microM) antagonized the effects of NECA on contractile response and evoked a cAMP-increasing effect of NECA, which was 38% of the isoprenaline value at most. In contrast, CGS 15943A did not affect the reduction of contractile response induced by NECA, whereas CGS 15943A revealed a cAMP-decreasing effect of NECA (0.1-10 microM). This study provides functional evidence that both, cAMP-decreasing A1- and cAMP-increasing A2-adenosine receptors are present on ventricular cardiomyocytes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168481

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs.

Authors:  R Z Gerencer; B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

2.  Negative chronotropic and inotropic effects exerted by diadenosine hexaphosphate (AP6A) via A1-adenosine receptors.

Authors:  U Vahlensieck; P Bokník; J Knapp; B Linck; F U Müller; J Neumann; S Herzig; H Schlüter; W Zidek; M C Deng; H H Scheld; W Schmitz
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Regulation of A1 adenosine receptors by amiodarone and electrical stimulation in rat myocardial cells in vitro.

Authors:  D El-Ani; K A Jacobson; A Shainberg
Journal:  Biochem Pharmacol       Date:  1997-09-01       Impact factor: 5.858

Review 4.  The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions.

Authors:  Joachim Neumann; Uwe Kirchhefer; Stefan Dhein; Britt Hofmann; Ulrich Gergs
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

5.  Contractile effects of adenosine, coronary flow and perfusion pressure in murine myocardium.

Authors:  Laura Willems; John P Headrick
Journal:  Pflugers Arch       Date:  2006-10-28       Impact factor: 3.657

6.  125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.

Authors:  T M Palmer; S M Poucher; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1995-12       Impact factor: 4.436

7.  Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea-pig hearts.

Authors:  T Bethke; W Meyer; W Schmitz; H Scholz; B Stein; K Thomas; H Wenzlaff
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

8.  Signal transduction pathway of the muscarinic receptors mediating gallbladder contraction.

Authors:  T von Schrenck; B Mackensen; U Mende; W Schmitz; J Sievers; S Mirau; A Raedler; H Greten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

9.  A positive inotropic effect of adenosine in cardiac preparations of right atria from diseased human hearts.

Authors:  Ulrich Gergs; Peter Boknik; Wilhelm Schmitz; Andreas Simm; Rolf-Edgar Silber; Joachim Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-27       Impact factor: 3.000

10.  Adenosine-sensitive alpha 1-adrenoceptor effects on reperfused ischaemic hearts: comparison with phorbol ester.

Authors:  N Khandoudi; M P Moffat; M Karmazyn
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.